In this NBC Nightly News video, watch UCLA Jonsson Comprehensive Cancer Center researcher Dr. Dennis Slamon discuss a new study that reports that treating women with a combination of chemotherapy and the molecularly targeted drug Herceptin can significantly increase survival in patients with a specific genetic mutation that results in very aggressive disease.
Video Rating: 5 / 5

Pharmacogenetics is becoming increasingly relevant in the diagnosis, treatment, and recovery of cancer patients. A major problem facing oncologists is the outstanding varied efficacy of treatment. Promising advances in pharmacogenetics have allowed the development of effective agents which will enable personalized cancer chemotherapy to become routine for the clinical practice. Written by experts in the field and combining information that is unable to be found in a single source volume, Pha

List Price: $ 179.95

Price:

(PRWEB) November 03, 2011

The American Society of Breast Surgeons, the leading organization for surgeons who treat breast disease, today released a video statement explaining its continued support of annual screening mammography for women age 40 and older.

The video, is an easy-to-understand follow-up to the Society’s official position statement, published in August, that stresses the importance of continuing the practice of annual mammographic screening, beginning at age 40, despite recommendations to the contrary by the United States Preventative Services Task Force.

In the video, Dr. Deanna Attai, chair of the Society’s Communications Committee and a member of its board of directors, explains that while most of the data indicating a survival benefit due to the early detection of breast cancer is in women older than age 50, studies confirm that mammographically detected breast cancers in younger women are smaller, earlier stage cancers which are associated with a higher rate of survival.

While mammography has some limitations—it may miss some breast cancers due to such factors as dense breast tissue, and, in some cases, it may result in some women undergoing additional imaging and even biopsy for suspected abnormalities that are ultimately found to be benign—Dr. Attai explains that screening mammography does remain the most cost-effective, practical and accurate screening tool currently available for the early detection of breast cancer.

“The importance of early detection cannot be emphasized enough,” says Dr Attai. The Society’s official statement asserts that women who are diagnosed with breast cancer in earlier stages are more likely to be candidates for breast-conserving surgery, are less likely to require chemotherapy, and will have an improved overall survival compared to women in whom their breast cancer is detected in more advanced stages.

The American Society of Breast Surgeons, the primary leadership organization for general surgeons who treat patients with breast disease, is committed to continually improving the practice of breast surgery by serving as an advocate for surgeons who seek excellence in the care of breast patients. The Society, with a membership of nearly 3,000 surgeons, promotes education, research and the development of advanced surgical techniques.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

This digital document is a journal article from Biological Psychology, published by Elsevier in 2005. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
Chemotherapy for breast cancer leads to increased fatigue, poor mood, and reduced quality of life. Few studies have examined possible changes in inflammation during chemotherapy as potential contributors to this phenom

List Price: $ 7.95

Price:

US $9.99 End Date: Sunday Feb-05-2012 5:53:31 PST Buy It Now for only: US $9.99 Buy it now | Add to watch list

US $46.95 End Date: Thursday Feb-09-2012 11:45:40 PST Buy It Now for only: US $46.95 Buy it now | Add to watch list

See a physician approved and licensed by the state and California Medical Board.

Thousand Oaks, CA (PRWEB) November 15, 2011

Cannamed, the oldest medical marijuana evaluation center in Ventura County, has recently opened two new offices – one in Woodland Hills, and one in Santa Barbara.

Cannamed, established in 2004, has made a name for itself in California by following the rules set forth by the California Medical Board. The president is Louis J. Rosner, M.D., a retired professor of neurology at UCLA. Dr. Rosner taught neurology, did research, and saw new patients at UCLA Medical Center until his retirement in 2000. He ran the UCLA Multiple Sclerosis (MS) Clinic, and wrote “Multiple Sclerosis: New Hope and Practical Advice for Patients and their Families,” which is highly regarded within the MS community. In the book, he discuses the value of marijuana use in patients with MS.

Dr. Rosner is well-versed in the use of medical marijuana for pain management. He advises that medical marijuana should be recommended to patients by doctors who are knowledgeable in pain management. He also states that a thorough physical examination should be given, not a virtual conference online, before the recommendation is given. Doctors at medical marijuana clinics approve or recommend marijuana but do not prescribe it.

Conditions in which marijuana is valuable include chronic pain conditions such as: arthritis, fibromyalgia, cervical disc disease, lumbar disc disease, carpal tunnel syndrome, post-herpetic neuralgia, plantar fasciitis, menstrual cramps, migraine headaches, and peripheral neuropathy.

It can also be very effective in mood disorders, including: anxiety, panic attacks, bipolar disorder, depression, and post-traumatic stress disorder.

Other conditions that are responsive to marijuana include: insomnia, anorexia, asthma, glaucoma, acid reflux, irritable bowel syndrome, Crohn’s disease, chemotherapy side effects, nausea and vomiting, menopause, epilepsy, restless legs syndrome, and sleep apnea.

For more information about medical marijuana, or to book an appointment online, please visit Cannamed online at http://www.cannamed.com, or call toll-free at 866-624-1191. Cannamed is licensed and approved by the State of California Medical Board.

Professor Louis J. Rosner, M.D.

CA License # C20800

CANNAMEDS FNP# 41874

# # #

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Related Chemotherapy Side Effects Press Releases

For the first time ever, there is a book that speaks to anyone, with any stage of breast cancer, and provides scientific methodology with accompanying tools, decision matrices, guidance and support, peppered with amazing humor. The book provides strategy on how to determine and select life saving or life threatening treatment planning in an uncertain decision space. After reading this book, you will be able to establish and maintain continual communication with your medical team, achieve the out

Price:

US $9.99 End Date: Sunday Feb-05-2012 5:53:31 PST Buy It Now for only: US $9.99 Buy it now | Add to watch list

US $46.95 End Date: Thursday Feb-09-2012 11:45:40 PST Buy It Now for only: US $46.95 Buy it now | Add to watch list

Related Chemotherapy Breast Cancer Products

ActosCancer.com – Helping those affected by the side effects of Actos

Orlando, FL (PRWEB) November 17, 2011

Although the FDA only months ago issued a warning about the serious risks for bladder cancer associated with the diabetes drug Actos, the response from patients affected by the drug has been shocking.

Thousands of people diagnosed with bladder cancer after taking Actos have sought help in determining their legal rights against the maker of the drug, Takeda Pharmaceuticals.

On August 31, 2011, lawyers representing Nevada plaintiffs Glen and Nina Weant filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) in Case NYE/1:11-cv-04502 asking that all federal Actos lawsuits be consolidated in an MDL court in the U.S. District Court for the Southern District of Illinois before Judge Murphy.

According to the motion, more than 12 lawsuits in 8 different federal district courts throughout the United States have been filed by patients who developed bladder cancer after taking Actos. The US Judicial Panel on Multidistrict Litigation has scheduled a hearing for December 1, 2011 to decide whether Actos lawsuits will be consolidated into an MDL.

A June 9, 2011 article in Bloomberg identified Actos as the leading diabetes treatment in the world, likely taken by millions of people. Sales of the drug were bolstered after studies in 2007 linked competitor Avandia to heart attacks and cardiovascular death.

On June 15, 2011, the U.S. FDA issued a warning that patients taking Actos for periods longer than one year could face an increased risk of developing actos bladder cancer.

The warning was based on an interim review of data from an ongoing 10-year study ordered by the FDA as well as a study by the French Medicines Agency. The French study tracked 155,000 patients taking the drug over four years, compared with 1.3 million diabetics not on the drug.

After a finding by the French study that those taking Actos for more than one year could face up to a 40% increase in the occurrence of bladder cancer, authorities in France and Germany halted use of the drug. The European Medicines Agency and FDA have issued strong warnings, but have not yet ordered a stop in sales.

According to the FDA, bladder cancer normally affects only 20 people out of 100,000. The National Cancer Institute claims there have been 69,250 new cases so far in 2011 with 14,990 deaths. However, the disease is considered highly treatable as the symptoms allow for early detection.

Actos was approved by the FDA in 1999 for the treatment of type II diabetes. According to the June 9, 2011 Bloomberg article, Japanese drug maker Takeda Pharmaceuticals earned $ 4.8 billion last year from sales of Actos alone.

Treatment of bladder cancer can require targeted chemotherapy as well as surgery to remove tumors or the entire bladder. Patients can face pain, long term disruption of bodily functions like urination and sexual ability, or even death.

Due to the extensive treatment, loss of function and long term medical monitoring required, damages for Actos bladder cancer could reach into the millions of dollars. Since there is a time limit on how long you have to take action, it is important for anyone affected to learn their legal options as soon as possible.

As with any highly-specialized case, an actos lawsuit is a very complex legal matter which could require extensive investigation and years of preparation. Before selecting a lawyer for help, make sure they have experience fighting large drug companies.

ActosCancer.com contains information on Actos, the research and side effects linked to the drug, as well as symptoms and treatment options for bladder cancer and how to find a lawyer who can help you recover.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Find More Chemotherapy Side Effects Press Releases

Price:

An extensive assessment of combination therapy of AIDS. Main focus is put on the Highly Active Antiretroviral Therapy (HAART) but other therapies like salvage therapy are also discussed. The chapters cover efficacy, treatment, causes of treatment failure, clinical care, guidelines, pharmacology. The volume closes with an outlook on future perspectives.

List Price: $ 209.00

Price:

Find More Chemotherapy Cost Products